Payment overview · 2025
General Payments
$53,028.20
86 reported records · 12 companies
Healthcare provider profile · identity verified
Elliot Ho, D.O.
Allopathic & Osteopathic Physicians|Internal Medicine · LOMA LINDA, CA · NPI 1184044760
Verified facts
What the public records show
CMS Open Payments records show Elliot Ho, D.O. received $53,028.20 in general payments during 2025 across 86 reported records.
INTUITIVE SURGICAL, INC. accounted for 71.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 17 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| INTUITIVE SURGICAL, INC. | Unresolved — no canonical attribution shown | $37,682.46 | 71.1% | 32 | 2025 |
| Olympus Corporation of the Americas | Unresolved — no canonical attribution shown | $10,027.42 | 18.9% | 19 | 2025 |
| Olympus America Inc. | Unresolved — no canonical attribution shown | $2,138.47 | 4.0% | 9 | 2025 |
| Olympus Medical Systems Corporation | Unresolved — no canonical attribution shown | $1,337.50 | 2.5% | 2 | 2025 |
| Pinnacle Biologics, Inc | Unresolved — no canonical attribution shown | $845.87 | 1.6% | 12 | 2025 |
| Noah Medical Corporation | Unresolved — no canonical attribution shown | $437.50 | 0.8% | 2 | 2025 |
| ERBE USA Inc | Unresolved — no canonical attribution shown | $262.33 | 0.5% | 3 | 2025 |
| Siemens Medical Solutions USA, Inc. | Unresolved — no canonical attribution shown | $124.91 | 0.2% | 1 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $64.74 | 0.1% | 2 | 2025 |
| Fujifilm Healthcare Americas Corporation | Unresolved — no canonical attribution shown | $47.99 | 0.1% | 2 | 2025 |
| Pulmonx Corporation | Unresolved — no canonical attribution shown | $39.59 | 0.1% | 1 | 2025 |
| ERBE USA INC | Unresolved — no canonical attribution shown | $19.42 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $26,560.00 | 11 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,105.00 | 6 |
| Travel and Lodging | $3,388.26 | 14 |
| Food and Beverage | $3,199.94 | 51 |
| Consulting Fee | $1,775.00 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Da Vinci Surgical System Normalized: da vinci surgical system |
Device | INTUITIVE SURGICAL, INC. | $37,682.46 | 32 | 2025 |
Source payment records
|
|||||
| EVES EUS ULTRASOUND BRONCHOFIBERVIDEOSCOPE Normalized: eves eus ultrasound bronchofibervideoscope |
Device | Olympus Corporation of the Americas | $8,730.57 | 11 | 2025 |
Source payment records
|
|||||
| SINGLE USE SUCTION VALVE (Sterile) Normalized: single use suction valve sterile |
Device | Olympus Corporation of the Americas | $8,730.57 | 11 | 2025 |
Source payment records
|
|||||
| Single Use Aspiration Needle NA-U401SX Normalized: single use aspiration needle na u401sx |
Device | Olympus Corporation of the Americas | $8,730.57 | 11 | 2025 |
Source payment records
|
|||||
| Photofrin Normalized: photofrin |
Drug | Pinnacle Biologics, Inc | $845.87 | 12 | 2025 |
Source payment records
|
|||||
| GALAXY Normalized: galaxy |
Device | Noah Medical Corporation | $437.50 | 2 | 2025 |
Source payment records
|
|||||
| VIO Cryo APC Normalized: vio cryo apc |
Device | ERBE USA Inc | $221.29 | 1 | 2025 |
Source payment records
|
|||||
| WAYNE Normalized: wayne |
Device | Cook Medical LLC | $60.30 | 1 | 2025 |
Source payment records
|
|||||
| Single-Use flexible Video Bronchoscope Normalized: single use flexible video bronchoscope |
Device | Olympus America Inc. | $58.83 | 1 | 2025 |
Source payment records
|
|||||
| FUJIFILM Normalized: fujifilm |
Device | Fujifilm Healthcare Americas Corporation | $47.99 | 2 | 2025 |
Source payment records
|
|||||
| CRYO2 Normalized: cryo2 |
Device | ERBE USA INC, ERBE USA Inc | $39.94 | 2 | 2025 |
Source payment records
|
|||||
| CHARTIS CATHETER Normalized: chartis catheter |
Device | Pulmonx Corporation | $39.59 | 1 | 2025 |
Source payment records
|
|||||
| PULMONX CHARTIS TABLET CONSOLE Normalized: pulmonx chartis tablet console |
Device | Pulmonx Corporation | $39.59 | 1 | 2025 |
Source payment records
|
|||||
| ZEPHYR DELIVERY CATHETER Normalized: zephyr delivery catheter |
Device | Pulmonx Corporation | $39.59 | 1 | 2025 |
Source payment records
|
|||||
| ZEPHYR ENDOBRONCHIAL VALVE Normalized: zephyr endobronchial valve |
Device | Pulmonx Corporation | $39.59 | 1 | 2025 |
Source payment records
|
|||||
| ErbeCryo2 Normalized: erbecryo2 |
Device | ERBE USA Inc | $20.52 | 1 | 2025 |
Source payment records
|
|||||
| ECHOTIP PROCORE Normalized: echotip procore |
Device | Cook Medical LLC | $4.44 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $53,028.20 · 86 records | INTUITIVE SURGICAL, INC. | CHARTIS CATHETER, CRYO2, Da Vinci Surgical System, ECHOTIP PROCORE, EVES EUS ULTRASOUND BRONCHOFIBERVIDEOSCOPE, ErbeCryo2, FUJIFILM, GALAXY, PULMONX CHARTIS TABLET CONSOLE, Photofrin, SINGLE USE SUCTION VALVE (Sterile), Single Use Aspiration Needle NA-U401SX, Single-Use flexible Video Bronchoscope, VIO Cryo APC, WAYNE, ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error